Home R&D Page 3

R&D

Theramex to commercialise denosumab from Enzene Biosciences
Featured

Theramex to commercialise denosumab from Enzene Biosciences

Dominic Cuthbert -
0
Amgen and Kyowa Kirin to develop potential first-in-class treatment for atopic dermatitis
Featured

Amgen and Kyowa Kirin to develop potential first-in-class treatment for atopic dermatitis

Dominic Cuthbert -
0
Centivax and US Naval Medical Research Center forge strategic partnership
Featured

Centivax and US Naval Medical Research Center forge strategic partnership

Dominic Cuthbert -
0
Novartis and Molecular Partners begin EMPATHY clinical trial for ensovibep in COVID-19
Featured

Novartis and Molecular Partners begin EMPATHY clinical trial for ensovibep in COVID-19

Dominic Cuthbert -
0
Pieris enters respiratory & ophthalmology collaboration with Genentech
Featured

Pieris enters respiratory & ophthalmology collaboration with Genentech

Dominic Cuthbert -
0
Excenstia forges $1.2bn AI drug discovery deal with BMS
Featured

Excenstia forges $1.2bn AI drug discovery deal with BMS

Dominic Cuthbert -
0
BMS gains license to Agenus’ proprietary bispecific antibody programme
Featured

BMS gains license to Agenus’ proprietary bispecific antibody programme

Dominic Cuthbert -
0
FDA clears IND application for novel allogeneic variable delta 1 gamma-delta T cell cancer therapy
Featured

FDA clears IND application for novel allogeneic variable delta 1 gamma-delta T cell cancer therapy

Tess Egginton -
0
Lilly & MiNA Therapeutics forge saRNA research collaboration
Featured

Lilly & MiNA Therapeutics forge saRNA research collaboration

Dominic Cuthbert -
0
NIH scientists identify small-molecule cocktail to improve stem cell use
Featured

NIH scientists identify small-molecule cocktail to improve stem cell use

Dominic Cuthbert -
0
1234...186Page 3 of 186

© 2020 Part of the Business Link Magazine Group. Armstrong House, Armstrong Street, Grimsby,
North East Lincolnshire, DN31 2QE

About Us

Popular Category

Editor Picks